Emergence and clonal dissemination of carbapenem-hydrolysing OXA-58-producing Acinetobacter baumannii isolates in Bolivia

Journal of Medical Microbiology

Volumn 61, Issue 1, 2012, Pages 80-84

  Sevillano, Elena ^a   Fernández, Elena ^a   Bustamante, Zulema ^b   Zabalaga, Silvia ^b   Rosales, Ikerne ^a   Umaran, Adelaida ^a   Gallego, Lucía ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b UNIVERSIDAD MAYOR DE SAN SIMÓN   (Bolivia)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEMASE; COLISTIN; IMIPENEM; OXA 58 CARBAPENEMASE; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; BOLIVIA; CHILD; CLINICAL ARTICLE; FEMALE; GENOTYPE; HUMAN; INFANT; MALE; MINIMUM INHIBITORY CONCENTRATION; NEWBORN; NONHUMAN; PLASMID; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SCHOOL CHILD; WOUND;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADOLESCENT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BOLIVIA; CARBAPENEMS; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HOSPITALS; HUMANS; IMIPENEM; INFANT; INFANT, NEWBORN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PLASMIDS; YOUNG ADULT;

EID: 83755183391     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.032722-0     Document Type: Article

References (34)

1. Bertini, A., Giordano, A., Varesi, P., Villa, L., Mancini, C. & Carattoli, A. (2006). First report of the carbapenem-hydrolyzing oxacillinase OXA-58 in Acinetobacter baumannii isolates in Italy. Antimicrob Agents Chemother 50, 2268-2269.
2. Canduela, M. J., Gallego, L., Sevillano, E., Valderrey, C., Calvo, F. & Pérez, J. (2006). Evolution of multidrug-resistant Acinetobacter baumannii isolates obtained from elderly patients with respiratory tract infections. J Antimicrob Chemother 57, 1220-1222.
3. Celenza, G., Pellegrini, C., Caccamo, M., Segatore, B., Amicosante, G. & Perilli, M. (2006). Spread of blaCTX-M-type and blaPER-2 b-lactamase genes in clinical isolates from Bolivian hospitals. J Antimicrob Chemother 57, 975-978.
4. CLSI (2007). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, 7th edn; Approved Standard. M7-A7. Wayne, PA, USA: Clinical and Laboratory Standards Institute.
5. Coelho, J., Woodford, N., Afzal-Shah, M. & Livermore, D. (2006). Occurrence of OXA-58-like carbapenemases in Acinetobacter spp. collected over 10 years in three continents. Antimicrob Agents Chemother 50, 756-758.
6. Gallego, L. & Towner, K. J. (2001). Carriage of class 1 integrons and antibiotic resistance in clinical isolates of Acinetobacter baumannii from northern Spain. J Med Microbiol 50, 71-77.
7. Héritier, C., Dubouix, A., Poirel, L., Marty, N. & Nordmann, P. (2005). A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolysing oxacillinase OXA-58. J Antimicrob Chemother 55, 115-118.
8. Higgins, P. G., Poirel, L., Lehmann, M., Nordmann, P. & Seifert, H. (2009). OXA-143, a novel carbapenem-hydrolyzing class D blactamase in Acinetobacter baumannii. Antimicrob Agents Chemother 53, 5035-5038.
9. Higgins, P. G., Dammhayn, C., Hackel, M. & Seifert, H. (2010a). Global spread of carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother 65, 233-238.
10. Higgins, P. G., Lehmann, M. & Seifert, H. (2010b). Inclusion of OXA-143 primers in a multiplex polymerase chain reaction (PCR) for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 35, 305.
11. Higgins, P. G., Lehmann, M., Wisplinghoff, H. & Seifert, H. (2010c). Gyrb multiplex PCR to differentiate between Acinetobacter calcoaceticus and Acinetobacter genomic species 3. J Clin Microbiol 48, 4592-4594.
12. Kulah, C., Mooij, M. J., Comert, F., Aktas, E., Celebi, G., Ozlu, N., Rijnsburger, M. C. & Savelkoul, P. H. M. (2010). Characterisation of carbapenem-resistant Acinetobacter baumannii outbreak strains producing OXA-58 in Turkey. Int J Antimicrob Agents 36, 114-118.
13. Lee, K., Lim, Y. S., Yong, D., Yum, J. H. & Chong, Y. (2003). Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-b-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 41, 4623-4629.
14. Marqué, S., Poirel, L., Héritier, C., Brisse, S., Blasco, M. D., Filip, R., Coman, G., Naas, T. & Nordmann, P. (2005). Regional occurrence of plasmid-mediated carbapenem-hydrolyzing oxacillinase OXA-58 in Acinetobacter spp. in Europe. J Clin Microbiol 43, 4885-4888.
15. McCracken, M., DeCorby, M., Fuller, J., Loo, V., Hoban, D. J., Zhanel, G. G. & Mulvey, M. R. (2009). Identification of multidrug- and carbapenem-resistant Acinetobacter baumannii in Canada: results from CANWARD 2007. J Antimicrob Chemother 64, 552-555.
16. Mendes, R. E., Bell, J. M., Turnidge, J. D., Castanheira, M. & Jones, R. N. (2009). Emergence and widespread dissemination of OXA-23, - 24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program. J Antimicrob Chemother 63, 55-59.
17. Papa, A., Koulourida, V. & Souliou, E. (2009). Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in a newly established Greek hospital. Microb Drug Resist 15, 257-260.
18. Poirel, L., Marqué, S., Héritier, C., Segonds, C., Chabanon, G. & Nordmann, P. (2005). OXA-58, a novel class D b-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob Agents Chemother 49, 202-208.
19. Poirel, L., Naas, T. & Nordmann, P. (2010). Diversity, epidemiology, and genetics of class D b-lactamases. Antimicrob Agents Chemother 54, 24-38.
20. Queenan, A. M. & Bush, K. (2007). Carbapenemases: the versatile b-lactamases. Clin Microbiol Rev 20, 440-458.
21. Robledo, I. E., Aquino, E. E., Santé, M. I., Santana, J. L., Otero, D. M., León, C. F. & Vázquez, G. J. (2010). Detection of KPC in Acinetobacter spp. in Puerto Rico. Antimicrob Agents Chemother 54, 1354-1357.
22. Rossi, F., García, P., Ronzon, B., Curcio, D. & Dowzicky, M. J. (2008). Rates of antimicrobial resistance in Latin America (2004-2007) and in vitro activity of the glycylcycline tigecycline and of other antibiotics. Braz J Infect Dis 12, 405-415.
23. Sader, H. S., Jones, R. N., Gales, A. C., Silva, J. B., Pignatari, A. C. & SENTRY Participants Group (Latin America) (2004). SENTRY antimicrobial surveillance program report: Latin American and Brazilian results for 1997 through 2001. Braz J Infect Dis 8, 25-79.
24. Sader, H. S., Castanheira, M., Mendes, R. E., Toleman, M., Walsh, T. R. & Jones, R. N. (2005). Dissemination and diversity of metallo-blactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program. Int J Antimicrob Agents 25, 57-61.
25. Sambrook, J. & Russell, D. W. (2001). Molecular Cloning: a Laboratory Manual, 3rd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
26. Sevillano, E., Gallego, L. & Garca-Lobo, J. M. (2009). First detection of the OXA-40 carbapenemase in P. aeruginosa isolates, located on a plasmid also found in A. baumannii. Pathol Biol (Paris) 57, 493-495.
27. Sgambatti, S., Gales, A. C. & Sader, H. S. (2010). Antimicrobial resistance in Gram-negative bacteria from developing countries. In Antimicrobial Resistance in Developing Countries, pp. 249-266. Edited by A. De J Sosa, D. K. Byarugaba, C. F. Amábile-Cuevas, P. R. Hsueh, S. Kariuki & I. N. Okeke. New York, Dordrecht, Heidelberg, London: Springer.
28. Souli, M., Galani, I. & Giamarellou, H. (2008). Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe. Euro Surveill 13, 1-11.
29. Tenover, F. C., Arbeit, R. D., Goering, R. V., Mickelsen, P. A., Murray, B. E., Persing, D. H. & Swaminathan, B. (1995). Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33, 2233-2239.
30. Tognim, M. C. B., Andrade, S. S., Silbert, S., Gales, A. C., Jones, R. N. & Sader, H. S. (2004). Resistance trends of Acinetobacter spp. in Latin America and characterization of international dissemination of multidrug resistant strains: five-year report of the SENTRY Antimicrobial Surveillance Program. Int J Infect Dis 8, 284-291.
31. Turton, J. F., Kaufmann, M. E., Warner, M., Coelho, J., Dijkshoorn, L., van der Reijden, T. & Pitt, T. L. (2004). A prevalent, multiresistant clone of Acinetobacter baumannii in Southeast England. J Hosp Infect 58, 170-179.
32. Walsh, T. R. (2010). Emerging carbapenemases: a global perspective. Int J Antimicrob Agents 36 (Suppl. 3), S8-S14.
33. Wang, H., Guo, P., Sun, H., Wang, H., Yang, Q., Chen, M., Xu, Y. & Zhu, Y. (2007). Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals. Antimicrob Agents Chemother 51, 4022-4028.
34. Woodford, N., Ellington, M. J., Coelho, J. M., Turton, J. F., Ward, M. E., Brown, S., Amyes, S. G. & Livermore, D. M. (2006). Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 27, 351-353.